2-methoxy-4-[3-(pyridin-4-y)l-[1,2,4]oxadiazol-5-yl]-phenol | 1347755-40-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-methoxy-4-[3-(pyridin-4-y)l-[1,2,4]oxadiazol-5-yl]-phenol
• 英文别名: 2-Methoxy-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol；2-methoxy-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol
• CAS: 1347755-40-1
• 化学式: C₁₄H₁₁N₃O₃
• 分子量: 269.26
• InChiKey: RNJJAWQYVXIBGD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  81.3
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-吡啶基偕胺肟 、 香草醛 反应 0.12h， 以81%的产率得到2-methoxy-4-[3-(pyridin-4-y)l-[1,2,4]oxadiazol-5-yl]-phenol
  参考文献：
  名称：

  Synthesis anti-inflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives

  摘要：

  Pyrazole derivatives IIa-l have been synthesized by condensation of chalcones Ia-f with hydrazine hydrate and phenyl hydrazine under microwave irradiation in good yields. Oxadiazole derivatives IVa-f have been synthesized by condensation of N'-hydroxypicolinamidine, N'-hydroxy isonicotinamidine, N'-hydroxypyrazine-2-carboxamidine with 2,5 dimethoxybenzaldehyde and 3-methoxy-4-hydroxy benzaldehyde, respectively. Structures assigned to IIa-l and IVa-f are fully supported by correct spectral and analytical data. All compounds (IIa-l & IVa-f) have been screened for anti-inflammatory and anticancer activities. Compounds IIj, IIk, and IVb exhibited good anti-inflammatory activity, while, IIa, c, j, and IVd showed better anticancer activity against four and three cancer cell lines, respectively.

  DOI：

  10.1007/s00044-011-9850-7

文献信息

• Synthesis anti-inflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives
  作者：Sham M. Sondhi、Sandeep Kumar、Nikhil Kumar、Partha Roy

  DOI：10.1007/s00044-011-9850-7

  日期：2012.10

  Pyrazole derivatives IIa-l have been synthesized by condensation of chalcones Ia-f with hydrazine hydrate and phenyl hydrazine under microwave irradiation in good yields. Oxadiazole derivatives IVa-f have been synthesized by condensation of N'-hydroxypicolinamidine, N'-hydroxy isonicotinamidine, N'-hydroxypyrazine-2-carboxamidine with 2,5 dimethoxybenzaldehyde and 3-methoxy-4-hydroxy benzaldehyde, respectively. Structures assigned to IIa-l and IVa-f are fully supported by correct spectral and analytical data. All compounds (IIa-l & IVa-f) have been screened for anti-inflammatory and anticancer activities. Compounds IIj, IIk, and IVb exhibited good anti-inflammatory activity, while, IIa, c, j, and IVd showed better anticancer activity against four and three cancer cell lines, respectively.